Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's DiseaseAlzheimer's Disease (AD)Active, not recruitingPhase 1 / Phase 22025-11-19NCT06874621

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Voyager Therapeutics2

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
VYGR Site 124001TorontoCanada1
VYGR Site 124002OttawaCanada1
VYGR Site 124003MontrealCanada1
VYGR Site 124004MontrealCanada1
VYGR Site 840002WellingtonUnited States1
VYGR Site 840003StuartUnited States1
VYGR Site 840004The VillagesUnited States1
VYGR Site 840005Delray BeachUnited States1
VYGR Site 840006OrlandoUnited States1
VYGR Site 840007DecaturUnited States1
VYGR Site 840008StamfordUnited States1
VYGR Site 840009MatthewsUnited States1
VYGR Site 840010Lady LakeUnited States1
VYGR Site 840011Plymouth MeetingUnited States1
VYGR Site 840012Toms RiverUnited States1
VYGR Site 840014MiamiUnited States1
VYGR Site 840015MiamiUnited States1
VYGR Site 840016OrangeUnited States1
VYGR Site 840018Los AngelesUnited States1
VYGR Site 840020Winter ParkUnited States1
VYGR Site 840021Fort MyersUnited States1
VYGR Site 840022San FranciscoUnited States1
VYGR Site 840024MiamiUnited States1